Private equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of medical products to ...
Barrington analyst Michael Petusky raised the firm’s price target on Henry Schein (HSIC) to $90 from $82 and keeps an Outperform rating on the ...
(Reuters) - Private-equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of ...
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...